bims-tumhetTumor Heterogeneity
This report is maintained by Sergio Marchini, Humanitas Research. It brings out roughly 7 papers per issue.
0000‒00‒00
 Sign up
2024–04–14
2024–04–07
0000‒00‒00
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
2024–03–31
2024–03–24
2024–03–17
2024–03–10
2024–03–03
2024–02–25
2024–02–18
2024–02–11
2024–02–04
2024–01–28
2024–01–21
2024–01–14
2024–01–07
2023–12–31
2023–12–24
2023–12–17
2023–12–10
2023–12–03
2023–11–26
2023–11–19
2023–11–12
2023–11–05
2023–10–29
2023–10–22
2023–10–15
2023–10–08
2023–10–01
2023–09–24
2023–09–17
2023–09–10
2023–09–03
2023–08–27
2023–08–20
2023–08–13
2023–08–06
2023–07–30
2023–07–23
2023–07–16
2023–07–09
2023–07–02
2023–06–25
2023–06–18
2023–06–11
2023–06–04
2023–05–28
2023–05–21
2023–05–14
2023–05–07
2023–04–30
2023–04–23
2023–04–16
2023–04–09
2023–04–02
2023–03–26
2023–03–19
2023–03–12
2023–03–05
2023–02–26
2023–02–19
2023–02–12
2023–02–05
2023–01–29
2023–01–22
2023–01–15
2023–01–08
2023–01–01
2022–12–25
2022–12–18
2022–12–11
2022–12–04
2022–11–27
2022–11–20
2022–11–13
2022–11–06
2022–10–30
2022–10–23
2022–10–16
2022–10–09
2022–10–02
2022–09–25
2022–09–18
2022–09–11
2022–09–04
2022–08–28
2022–08–21
2022–08–14
2022–08–07
2022–07–31
2022–07–24
2022–07–17
2022–07–10
2022–07–03
2022–06–26
2022–06–19
2022–06–12
2022–06–05
2022–05–29
2022–05–22
2022–05–15
2022–05–08
2022–05–01
2022–04–24
2022–04–17
2022–04–10
2022–04–03
2022–03–27
2022–03–20
2022–03–13
2022–03–06
2022–02–27
2022–02–20
2022–02–13
2022–02–06
2022–01–30
2022–01–23
2022–01–16
2022–01–09
2022–01–02
2021–12–26
2021–12–19
2021–12–12
2021–12–05
2021–11–28
2021–11–21
2021–11–14
2021–11–07
2021–10–31
2021–10–24
2021–10–17
2021–10–10
2021–10–03
2021–09–26
2021–09–19
2021–09–12
2021–09–05
2021–08–29
2021–08–22
2021–08–15
2021–08–08
2021–08–01
2021–07–25
2021–07–18
2021–07–11
2021–07–04
2021–06–27
2021–06–20
2021–06–13
2021–06–06
2021–05–30
2021–05–23
2021–05–16
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-ovdlit“Ovarian cancer: early diagnosis, liquid biopsy and therapy”, ∼ 4 p.p.i. ∼ 4 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-cagime“Cancer, aging and metabolism”, ∼ 36 p.p.i. ∼ 36 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-pideca“Class IA PI3K signalling in development and cancer”, ∼ 20 p.p.i. ∼ 20 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-instec“Intestinal stem cells and chemoresistance in colon cancer and intestinal regeneration”, ∼ 11 p.p.i. ∼ 11 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-camemi“Mitochondrial metabolism in cancer”, ∼ 45 p.p.i. ∼ 45 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-nimamd“Neuroimmunity and neuroinflammation in ageing and metabolic disease”, ∼ 51 p.p.i. ∼ 51 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-ectoca“Epigenetic control of tolerance in cancer”, ∼ 9 p.p.i. ∼ 9 papers per issue
This page is being maintained by Thomas Krichel. It was last updated on 2024‒04‒18 at 19:46.